Podcast appearances and mentions of Jim Mellon

Global Markets: What's Next? A Deep Dive into Macroeconomics, Markets & Future-Proof Investment Ideas. Join Wilfred Frost, renowned News Anchor at Sky News, in conversation with legendary investor and entrepreneur Jim Mellon at the Master Investor Show 2025. In this exclusive interview, Jim shares his sharp insights on the state of the US economy, upcoming political and market shifts, and how these developments are set to impact investors globally. They also explore emerging opportunities across asset classes and regions—from biotech to AI to alternative assets—offering actionable ideas and foresight into what the next big investment themes could be.

If you follow the world of cultivated meat, you probably know that a few companies have gotten historic regulatory approval and have sold some limited quantities of product both in the US and Singapore. But earlier this year, Meatly—a company founded only in 2021 and with just a few million British pounds in their pocket—succeeded in getting regulatory approval to start selling its cultivated chicken meat…in pet food. This was the first-ever European approval for a cultivated meat product, and the first-ever approval for such a product in the pet food space. And as someone with a dog who sadly makes his distaste for plant-based dog food very clear, I can assure you that I'm eager to see if my dog Eddie will enjoy Meatly's debut product.  In this episode, I talk with Meatly CEO Owen Ensor about his journey from starting the company to now. We discuss the scale he's at, the cost structure of his product, the inclusion rates in pet food he anticipates, what stores he plans to sell in at first, how he'll fund the company, when he thinks cultivated meat may make a dent in total meat demand, and much more.  It's a riveting conversation with someone making headlines across the alt-meat world. Will pet food be the gateway for cultivated meat's market entrance? You be the judge. Discussed in this episode Owen became vegan after watching Cowspiracy. Owen's chart showing the timeline to regulatory approval for various cultivated meat companies. Paul's essay on pet food's contribution to total meat demand. Bond is another company growing chicken protein for the pet market. You can see Paul's dog Eddie enjoying it here. Our past episodes with Jim Mellon from Agronomics and Mark Post from Mosa Meat. Owen recommends reading Good to Great. More about Owen Ensor Owen is the Founding CEO of Meatly. Since establishing Meatly in 2021, with only £3.5m in funding, it has become the first company in Europe to get regulatory approval for cultivated meat, developed industry-leading technical processes, and created the world's first cultivated pet food products. Before establishing Meatly, Owen started his career at the Management Consultancy company Bain and scaled one of the world's first insect protein facilities.

Interview with Mark Child, CEO of Condor Gold PLCOur previous interview: https://www.cruxinvestor.com/posts/condor-gold-cnr-primed-for-a-take-over-2557Recording date: 16th September 2024Condor Gold PLC, a London and Toronto-listed mining company, presents an intriguing investment opportunity in the gold sector with its La India project in Nicaragua. The company has positioned itself as a potential acquisition target, offering investors exposure to a high-grade, fully-permitted gold asset in a rising precious metals market.The La India project boasts a substantial 2.4 million ounce gold resource, with an impressive grade of 4 grams per tonne. Half of this resource is open pit, while the other half is underground. Condor Gold has completed a bankable feasibility study on the main pit, which represents about 40% of the total ounces.CEO Mark Child outlines three production scenarios:Reserve Case: 82,000 ounces of gold per annumOpen Pit Scenario: 120,000 ounces per annum (including feeder pits)Combined Open Pit and Underground: 150,000 ounces per annumA key strength of the project is its "shovel ready" status. Condor Gold has secured all necessary permits for construction and operation, as well as acquired all required surface rights, investing $45 million in land acquisition across 55 plots. This comprehensive approach significantly de-risks the project for potential buyers.The economic potential of La India is substantial, particularly in the current gold price environment. At $1,600/oz gold, the project demonstrates robust economics with a 23% IRR for the reserve pit. At $2,000/oz gold, EBITDA more than doubles to approximately $750 million for the reserve pit alone. The high-grade nature of the deposit provides significant leverage to gold prices, with minimal change in operating costs as prices rise.One of the most attractive aspects of the La India project is its relatively modest capital expenditure requirement of $105 million. This low initial capital outlay broadens the pool of potential acquirers, as it's within reach for mid-tier producers and even some junior miners.However, investors should be aware of the jurisdictional risks associated with Nicaragua. While the government is supportive of mining and there are other operating mines in the country, Nicaragua faces international scrutiny due to concerns about its democratic processes, resulting in U.S. sanctions on certain individuals and entities. These sanctions, while a consideration, do not directly impact mining operations.Condor Gold has engaged Hannam & Partners to run a formal sale process, with at least eight companies under confidentiality agreements and more expressing interest. The company's largest shareholder and chairman, Jim Mellon, who owns 26% of the company, is leading the sale negotiations, seeking a valuation that reflects the project's true worth. For investors, the significant disconnect between the company's market valuation (approximately $60 million) and the project's net present value (ranging from $350 million to $900 million) presents a potential opportunity. Any announcement of a transaction could result in a substantial re-rating of the stock.In conclusion, Condor Gold offers a high-risk, high-reward proposition for investors bullish on gold and willing to navigate the complexities of frontier market mining. The company's advanced-stage, high-grade asset, coupled with the ongoing sale process, provides a unique opportunity for potential value realization in the near term. However, investors should carefully consider the jurisdictional risks and uncertainties surrounding the sale process when evaluating this investment opportunity.View Condor Gold's company profile: https://www.cruxinvestor.com/companies/condor-goldSign up for Crux Investor: https://cruxinvestor.com

Has science cracked the code on mass producing realistic meat substitutes? Or are lab-gown alternative proteins an impossible dream? In this week's episode of Cleaning Up, Baroness Bryony Worthington sits down with president of the Good Food Institute, Bruce Friedrich, to explore the future of food. Friedrich details his vision for a more sustainable food system through technologies like plant-based and cultivated meat and outlines the promising progress and significant challenges remaining in scaling these novel proteins. Worthington and Friedrich debate the roles of policy, public opinion, and big agriculture in determining whether alternative proteins can truly transform our food system or remain forever niche.Links and more: The Good Food Institute (https://gfi.org) TEA of cultivated meat. Future projections for different scenarios (https://cedelft.eu/publications/tea-of-cultivated-meat/) A new land dividend: the opportunity of alternative proteins in Europe (https://green-alliance.org.uk/publication/a-new-land-dividend-the-opportunity-of-alternative-proteins-in-europe/) Recipe for a Livable Planet: Achieving Net Zero Emissions in the Agrifood System: (https://openknowledge.worldbank.org/entities/publication/406c71a3-c13f-49cd-8f3f-a071715858fb) UNEP Report on alternative proteins (https://www.unep.org/resources/whats-cooking-assessment-potential-impacts-selected-novel-alternatives-conventional) Episode 136 with Jim Mellon (https://www.youtube.com/watch?v=jqFPic5iqds)

Join Jess Larsen for an enlightening exchange with Jim Mellon, an esteemed investor and author whose expertise spans multiple industries. In this episode, Jim discusses his journey from early travels in Hong Kong to becoming a leading figure in the investment world. Delve into his transition from entrepreneurship to advocacy in longevity and health, where his far-sighted investments are shaping a new paradigm of living and working. Discover the insights that have driven him to write numerous books as he considers dedicating himself fully to authorship. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, Nick talks to Anthony Chow, Co-Founder of Agronomics. Anthony co-founded Argonomics in 2018 alongside author, entrepreneur and investor, Jim Mellon. Agronomics is the leading London listed company in the field of cellular agriculture. Cellular agriculture is the production of agriculture products directly from cell cultures that would have otherwise been derived from traditional agriculture methods. Nick and Anthony discuss cellular agriculture, looking at some of Anthony's key investments and discussing what the sector will look like in the next 5-10 years. Anthony's book choice was Material World: A Substantial Story of Our Past and Future by Ed Conway This content is issued by Zeus Capital Limited (“Zeus”) (Incorporated in England & Wales No. 4417845), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (“FCA”) for designated investment business, (Reg No. 224621) and is a member firm of the London Stock Exchange. This content is for information purposes only and neither the information contained, nor the opinions expressed within, constitute or are to be construed as an offer or a solicitation of an offer to buy or sell the securities or other instruments mentioned in it. Zeus shall not be liable for any direct or indirect damages, including lost profits arising in any way from the information contained in this material. This material is for the use of intended recipients only.

Jim Mellon is an author, entrepreneur and an investor with interests in a number of sectors. He has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies through his private investment company Burnbrae Group. After leaving Oxford, where he studied Philosophy, Politics and Economics, he worked in Asia and the United States in two fund management companies. Mr. Mellon is the co-author of five books, all written with a view to identifying emerging thematic trends leading to investment opportunities.  We had a great chat with Jim and learned about his in-depth and hands on experience within the field of cellular agriculture. --- Support this podcast: https://podcasters.spotify.com/pod/show/futurefoodshow/support

Double feature this week--here is the second day of Merryn's panel "The Butcher, the Brewer, the Baker." Again, it was held at Panmure House--Adam Smith's residence between 1778 and 1790. We taped this panel on August 27, 2023. Guests include: Jim Mellon, Richard Wilson, Paul Johnson and Simon Evans.Sign up to John Stepek's Money Distilled: https://www.bloomberg.com/account/newsletters/uk-wealthSee omnystudio.com/listener for privacy information.

This week's guest on Cleaning Up is entrepreneur, author and philanthropist Jim Mellon. Jim is Executive Director at Agronomics, one of the world's leading investors in cellular agriculture, or lab-grown meat. Bypassing traditional agricultural methods with precision fermentation could have huge implications for CO2 emissions and the climate, and in 2020 Jim wrote Moo's Law as a guide for fellow investors into what he calls the "new agrarian revolution."Jim and Michael discuss the latest developments in cellular agriculture - from pet food to leather goods and restaurant-grade sushi - and how far we are from finding lab-grown products on our supermarket shelves.  Links and Related EpisodesWatch Episode 110 with Lord Adair Turner: https://www.cleaningup.live/ep110-adair-turner-lord-of-the-net-zero-transition/Discover Agronomics and their portfolio companies here: https://agronomics.im/Read more about Moo's Law here: https://mooslawbook.com/Discover Jim's children's book, Juno's Ark, here: https://junosark.com/Jim spoke to Bloomberg's In The City podcast in April about Britain's economic health: https://www.bloomberg.com/news/articles/2023-04-06/podcast-burnbrae-s-jim-mellon-sees-a-bright-future-for-britain-and-the-city?in_source=embedded-checkout-banner#xj4y7vzkg Guest BioJim worked in Asia and the United States at two fund management companies, GT and Thornton, before establishing his own business in 1991. This business continues today, but Jim no longer works as a fund manager and is instead focused on biotech, clean food and property, with other business interests managed by his family office, the Burnbrae Group. Jim has a special interest in health resilience and longevity science, and is the co-founder of Juvenescence, a company investing in the development of therapies for ageing and the diseases of ageing. Jim also co-founded Agronomics Limited in 2011, an investment company focused on opportunities within the nascent industry of environmentally-friendly and cruelty-free modern foods.Jim holds a degree in Politics, Philosophy and Economics from Oriel College, Oxford, where he is an honorary fellow and supports the Mellon Scholarship in Ageing and Cell Senescence. 

The food system is responsible for one third of global emissions and it is estimated that livestock farming alone makes up 15% of global greenhouse gas emissions – that's almost as much as the entire transport sector.  But, with technology continuing to advance, will we be able to eat meat sustainably in the future?In this webinar, we explored the revolutionary food technology making its way on to the market with Thin Lei Win in conversation with Jim Mellon, Executive Director of Agronomics. This is the second discussion in our new ‘Critical Conversations' series with Mars Wrigley UK bringing together pioneers from different technologies looking to build our net-zero and no-carbon future. This event was recorded as part of a live webinar on 10 July 2023.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com. For more information, visit ElysabethAlfano.com. Connect with Elysabeth on Linked in here: https://www.linkedin.com/in/elysabeth-alfano-8b370b7/ For more PBH, visit ElysabethAlfano.com/Plantbased-Business-Hour.

H hears about businessman and author Jim Mellon's first book of childrens' fiction, "Juno's Ark", more from the redoubtable Wendy McDowell and another poem from the Manx Youth Bard.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com. For more information, visit ElysabethAlfano.com. Connect with Elysabeth on Linked in here: https://www.linkedin.com/in/elysabeth-alfano-8b370b7/ For more PBH, visit ElysabethAlfano.com/Plantbased-Business-Hour.

The outlook for the UK has improved in recent months, with a technical recession now looking like it will be avoided, according to Bloomberg Economics. In fact, the team sees GDP growth in 2023 of 0.1%, up from -0.4%.  Jim Mellon, chairman of Burnbrae, is predicting an even brighter picture. In this week's In the City, he tells hosts David Merritt and Francine Lacqua to look out for 1 to 2% growth this year, thanks to a more stable government, an influx of migrants and gas prices falling sharply.See omnystudio.com/listener for privacy information.

Graham Rowan, Chairman of Beaufort Private Equity, interviews Jim Mellon ahead of the forthcoming Master Investor Show (this recording was made before the date of the show was changed to the 15th of April 2023 due to rail strikes). For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Jim Mellon, co-founder of The Longevity Forum interview Peter Diamandis, Founder of the XPRIZE Foundation on breakthroughs for the next decade. There is no greater gift on the planet than adding healthy years to one's life. Our inability to live extraordinarily long is either a software problem or a hardware problem. Breakthroughs in diagnostics will help people understand early signs of ageing so we can catch disease from the beginning. In addition, therapeutics are evolving that may help with long term health.     https://thelongevityforum.com

With global uncertainty has come a renewed interest in precious metals in general, and gold in particular. In this podcast episode, Sarah Lowther discusses the gold outlook with major investor, Jim Mellon. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Today's episode is a remix of short clips from the previous weeks' episodes on guest's recommendations of must-read books. It serves as a teaser into the wealth of insights, entertaining anecdotes, and valuable tips from the various conversations to give you a flavor of the episode and guest.    If you like what you hear, I invite you to check out the full episodes! Further details you will find below.   Timestamps:  00:00 Introduction  01:00 Dr. Amy Killen - ‘The Giving Tree' by Shel Silverstein 01:42 Sergey Young - ‘The Science and Technology of Growing Young' by Serey Young 06:30 Dr. Dale Bredesen - ‘The Machinery of The Brain' by Dean Wooldridge 07:53 Sakiko Reuterskiold - ‘The Count of Monte Cristo' by Alexandre Dumas, ‘The Perennial Philosophy' by Aldous Huxley, ‘Brave New World' by Aldeous Huxley,  09:44 Dr. Joseph Raffaele - ‘Why We Age' by Steven Austad  11:49 Helen Reavey - ‘Atomic Habits' by James Clear  12:24 Marie Cudennec - ‘The Future We Choose' by Christina Figueres and Tom Rivett-Carnac, ‘The Sacred Cow' by Diana Rodgers and Robb Wolf 13:30 Dr. Mohammed Enayat - ‘Juvenescence: Investing in the Age of Longevity' by Jim Mellon and Al Chalabi,  and ‘The Core' by Aki Hintsa14:47 Dr. Kien Vuu - ‘The Thrive State' by Dr. Kien Vuu 18:31 Outro   Full Episode Titles: #3: Dr. Dale Bredesen On Why Cognitive Decline and Alzheimer's is Now Optional, How to Optimize Cognitive Function at Any Age, Testing, Protocols, the Changing Paradigm to 21st Century Medicine for Longevity, and much more #5: Science-Based Scalp Detoxing with Celebrity Hairstylist Helen Reavey, Co-Founder of Act+Acre, the World's First Sustainable Cold Processed Hair Wellness Brand Focusing on Scalp Health #10: Divine Organic Sweet Chocolate Without Sugar, What Fructose Actually Does to the Body, Aging and Performance, Keto Diets, Intermittent Fasting, Hormones, and Benefits of Organic Stevia with Sustainability-Focused NoMoSu Founder Sakiko Reuterskiöld #11: A Gym Knockout Mike Tyson-Style, an Explosion of New Ageing Technologies, How to Feel Half Your Age with Personalized Medicine, Wearables, Optimizing Hormones with PhysioAge Founder Dr. Joseph Raffaele #12: Transforming Our Planet with High-End Sustainable Furniture, Social Entrepreneurship, Responsible Consumerism, Environmental Action, Zero Hunger and Bespoke Designs with Marie Cudennac, Co-Founder of Goldfinger #14: Biohacking for Optimizing Human Performance, the Personalized Healthcare Revolution, Functional Medicine, and Collective Consciousness with Health Futurist and Physician Dr. Mohammed Enayat, Co-Founder of HUM2N #17: Living to 200 in a 25 Year-Old's Body, Helping 1 Billion People Extend Healthy Lifespan, Wearables, Aging as a Disease, Genetic Engineering, AI, Creativity and Responsibility with Longevity Investor and Innovator Sergey Young #18: The Bioenergetic Model, Treating Chronic Disease, Overcoming Adversity, Transforming Mindsets, Inner Confidence and the Future of Preventative Medicine with Performance and Longevity Doctor Kien Vuu #24: Dr. Amy Killen on Sex, Skin, Orgasms for Increased Lifespan, Regenerative and Preventative Medicine, Futuristic-like Procedures for Transformation, Stem Cells, Favorite Advice, Top Tips for Anti-Aging, Dinner Party Superpowers, and more! If you'd like to check out the full episode, simply go to   longevity-and-lifestyle.com/podcast.   For Podcast Show Notes & Transcript visit: https://longevity-and-lifestyle.com/podcast   Follow Claudia on: Instagram: https://www.instagram.com/longevityandlifestyle/?hl=en Facebook: https://www.facebook.com/longevityandlifestyle/ YouTube: https://www.youtube.com/channel/UCZF-s8jsUejc0TpVqnFE1lQ/featured  LinkedIn: https://www.linkedin.com/in/claudia-von-boeselager/ Twitter: https://twitter.com/LongevityLifest Website: https://longevity-and-lifestyle.com/    Past guests on The Longevity & Lifestyle Podcast include Dr. David Perlmutter, Dr. Amy Killen, Sergey Young, Dr. Dale Bredesen, Dr. Kristen Willeumier, Dr. Louise Newson, Dr. Kien Vuu, Dr. Carolina Reis, Marie Diamond, Nikolina Lauc, Morri Chowaiki, Leslie Kenny, Fiona O'Donnell-McCarthy, Mohamed Massaquoi, Nick Potter, Dr. Pamela Kryskow, Dr. Julia Mirer, Dr. Richard Johnson, Isabella Channing, Dina Burkitbayeva, Raewyn Guerrero, Mario Chamorro, Mariko Bangerter, Harris Khan, Juraj Kocar, Dr. Stephanie Manson Brown, Dr. Mohammed Enayat, Helen Reavey, Elena Letyagina, Dana Frost, Niall Breslin, Dr. Limor Goren and many more!

Jim Mellon co-founder of The Longevity Forum leads a discussion with Kristen Fortney, CEO and founder of BioAge Labs and James Peyer, CEO and founder of Cambrian Biopharma on the future of youth's interest in longevity. Ageing is universal – it happens to everyone compared to other diseases. Kristen and James discuss how organisations are working towards preventing this universal inevitability. From recent breakthroughs to the financial climate for biotech funding, these biotech pioneers open our eyes to the amazing progress in the industry.   https://bioagelabs.com   https://www.cambrianbio.com   https://thelongevityforum.com 

Having just interviewed Jim Mellon on a Food Innovation & Invement Summit panel, I thought it would be a good idea to re-run this interview. Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

Having just interviewed Jim Mellon on a Food Innovation & Invement Summit panel, I thought it would be a good idea to re-run this interview. Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

The field of longevity has long been considered to be theoretical and one for the future, but that future is here now. The science of ketosis promises lucrative opportunities in a wide range of therapeutic areas, and the global keto market is expected to rise to $15 billion by 2027. Juvenescence has brought together the leading experts in the ketone metabolism research field for a panel discussion on the revolution happening with ketones and the direction the research is leading the key players in this space. We cover how ketones can modulate fundamental aspects of human physiology, including glucose metabolism, brain function and heart health. Juvenescence was founded with a mission to transform what aging means to the world. Science around aging is accelerating at an extraordinary pace so we've set out to further that science through a coalition of the best scientists, physicians and investors creating cutting-edge therapies and products that will empower people to chart their own path forward. Our company represents a modality-agnostic portfolio of therapies developed by seasoned drug developers augmented by machine learning. We have raised over $200MM to date and are organized around two major divisions: JuvRx (Drug Therapies) and JuvLife (NonRx IP-protected and clinically-studied food ingredients and dietary supplements). Get the experts' insights on the latest research and development, hear from our founders, Dr. Greg Bailey and Jim Mellon on the opportunity areas in the market.

Entrepreneur and Longevity investor Jim Mellon talks about how the investment world is rapidly turning to longevity and sustainability for returns and as a result our expectations about ageing, performance and also how we can positively help the environment through changes in how we eat whilst also making ourselves healthier.Please make sure you like, subscribe, rate and review The Evolution Lab wherever you get your podcasts. It helps others discover the podcast more easily!The Evolution Lab is a Pod Prod Production. To find out more, go to www.podprod.co.uk

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

nvestor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

In this episode we talk to Anthony Chow Co-Founder of Agronomics. Agronomics invests in cultivated meat companies in order to disrupt the animal farming industry due to its impact to the environment and animal welfare. Following on from the chat with Jim Mellon, Executive Director of Agronomics we get key insights and updates from Anthony. We discuss what they look for when deciding which cultivated meat companies to invest in and how they tell the difference between real scientific innovation and hype. Additionally they have a keen interest to challenge the traditional leather industry and have invested in a company that creates cell-based leather without the cruelty. https://agronomics.im/ About PLANT CEO More people are choosing to follow plant-based diets or are reducing their meat intake. Exciting new startups are developing alternatives to traditional meat, dairy and seafood products, Whether it be food, fashion or health and beauty there are companies that are trying to change the way we consume products whilst reducing the impact on the planet. Hear from some of the inspirational entrepreneurs that are leading the way forward. https://plantceo.com/

Register to watch panel virtually on 9 Nov: https://thelongevityforum.com/registration-longevity-forum-2021 On this episode, Jim Mellon, co-founder of the Longevity Forum speaks with Henry Dimbleby, co-founder of Leon Foods and the lead on the National Food Strategy Report. The food system dominates the biosphere yet it has been collapsing from our harmful practices.  Without sustainable food, humankind is not sustainable. How can we work together with corporations and governments to ensure our agricultural practices keep us healthy and living longer? https://thelongevityforum.com

My guest Jim Mellon is an accomplished investor, entrepreneur, author and philanthropist. His most recent book called "Moo's Law" focuses on the investment opportunities in the field of cellular agriculture, which is a production of proteins and materials directly from stem cells.  Jim Mellon co-founded Agronomics to invest in a portfolio of leading companies in this sector, as he is its largest investor. In this conversation, we dig into this new area, we talk about the case for change, the challenges and opportunities, some of the people, and some of the nations that are driving and supporting these forward thinking cell-ag companies. What We Cover:  - How Jim developed his interest in biotech, longevity and cellular agriculture - Why industrial agriculture needs to change and what cell-ag offers to the world - The concepts of Moo's Law and griddle parity  - Which different categories of industry cellular agriculture are disrupting and revolutionising - The current state of cell-ag markets and products, and why Middle Eastern countries are faster to adopt this new industry - What challenges are facing the ramp up of cell-ag - The attractive characteristics of cell-ag companies for investors  - When we can expect cell-ag meat and fish to enter the European and US markets on larger scale Key Learnings and Takeaways:  - Moo's law suggests that as scale increases in the manufacture of foods in laboratory conditions, the efficiency will go up and the price will come down - Food-insecure countries such as Middle Eastern countries which import most of their food, will provide a model for implementing cell-ag for larger markets, such as the UK, EU and USA - The challenges facing cell-ag industry are performance of the stem cell lines on massive scale, using animals to continually provide more stem cells, and the execution of startup companies in this field   Links and Resources Mentioned in This Episode:  - Agronomics https://agronomics.im/  - Juvenescence https://www.juvlabs.com/  - ‘Moo's Law: An Investor's Guide to the New Agrarian Revolution' by Jim Mellon https://mooslawbook.com/  - 'Juvenescence: Investing in the Age of Longevity' by Jim Mellon https://www.amazon.com/Juvenescence-Investing-longevity-Mellon-Jim/dp/0993047815/  - 'Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes' by Jim Mellon https://www.amazon.com/Jim-Mellon/dp/1119963184/  - Blue Nalu https://www.bluenalu.com/  - Ivy Farm Technologies https://www.ivy.farm/  - Mohnish Pabrai: Cloning, Learning from Charlie Munger, 100 Baggers on OutsideVoices https://outsidelens.com/mohnish-pabrai-cloning/ - Joel Greenblatt: The Common Sense of Long-Term Investing on OutsideVoices https://outsidelens.com/joel-greenblatt-the-common-sense-of-long-term-investing/ Connect with Mark Bidwell: - LinkedIn https://www.linkedin.com/in/markbidwell/  - Twitter https://twitter.com/markehb

Jim Mellon is an accomplished investor, author and co-founder of Agronomics. His book "Moo's Law" focuses on the investment opportunities in the field of cellular agriculture.

Jim Mellon answers your questions in a live webinar.From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune.

It was great to have Jim Mellon, Chairman of Burnbrae Group come on PLANT CEO to speak about the future of food. Jim spent most of his career in investment management and biotech. We get to speak about his new book 'Moo's Law: An Investor's Guide to the New Agrarian Revolution', Agronomics: his company that invests into cell-based meat companies, TESLA, AI and bots, electric cars, ESG investing, human longevity, blue zones, growing a new liver inside your body, billionaires in space and English Pubs! https://burnbrae.com/ https://mooslawbook.com/ https://agronomics.im/ https://www.juvlabs.com/ About PLANT CEO More people are choosing to follow plant-based diets. Exciting new startups are disrupting this space by creating innovation in food, direct to consumer food delivery services, clothing, health care products and restaurants. We will be interviewing plant-based CEO's and established leaders in their own fields. Hear what drives these entrepreneurs, why they became vegan and learn more about their companies. https://plantceo.com/

Our second monthly Future of Longevity panel discussion featuring: George Church (Harvard Medical School) Nir Barzilai (Albert Einstein College of Medicine) Kristen Fortney (BioAge Labs) Jim Mellon (Juvenescence) Jay Olshansky (University of Illinois at Chicago) Alejandro Ocampo (University of Lausanne)

Jim Mellon tells Merryn which UK stocks he likes (and which ones he doesn't), why the future of meat is lab-grown, and why you should definitely have some oil in your portfolio.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

Jim Mellon’s a British investor, entrepreneur and philanthropist. It was 1979 when Jim got his start, in Hong Kong, as a trainee fund manager. When the fund was acquired eight years later, he received a windfall, becoming a millionaire in his late-twenties… And from that point forward, Jim has spread his bets far and wide, as an investor in emerging markets, commercial real estate, private and public companies—across many sectors; from financial services to mining to biotech and more. To view Jim’s current holdings, visit his company website: Burnbrae Group

The Sunday Times tech correspondent brings on Jim Mellon, the billionaire investor and co-founder of Agronomics, to talk about the lab-grown meat revolution (2:40), why he thinks he’s not too early (7:40), the dairy industry example (9:30), replacing traditional industries (11:00), why cultured meat will be bigger than electric vehicles (15:00), the carbon crackdown coming for meat (16:45), foetal bovine serum (20:40), what keeps him up at night (22:50), how cultured meat works (24:30), and the labelling fight (29:45). Support this show http://supporter.acast.com/dannyinthevalley. See acast.com/privacy for privacy and opt-out information.

Jim Mellon is the co-founder and Chairman of Juvenescence. Juvenescence was inspired by the possibilities and advances being made in the area of longevity. He travelled across the world speaking to leading scientists and researchers and from those conversations, he wrote the book, Juvenescence. That book and his partnership with Greg Bailey and Declan Doogan led to the concept and rare opportunity to reinvent human aging. Jim is an international investor with interests in several industries. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. ————————————————————————— For podcast transcripts and show notes, visit *salt.org/talks* ( http://salt.org/talks ) Watch this video on YouTube: *https://youtu.be/Kdyc5So_gYw* ( https://youtu.be/Kdyc5So_gYw ) Developed, created and produced by SALT Venture Group, LLC. Moderated by Anthony Scaramucci.

How often have you wished that more billionaires used their money to do good in the world? Well, you’re in luck, because in this episode we talk with British billionaire Jim Mellon. In recent years Jim’s been most well-known for his work on human longevity research, which we discuss. But he’s also become fixated on ending the factory farming of animals. As a result, Jim has learned an immensity about alternative protein and has invested in dozens of start-ups in the space via his fund Agronomics. He’s even just published a book on the topic, Moo’s Law, in which he discusses his views on the industry, which companies he thinks will be winners, and yes, which he thinks won’t make it.  As you’ll hear in this interview, Jim has little hope that humans will give up eating meat, so he’s betting instead on simply making meat without the animals.  In this conversation we discuss when he thinks such clean meat will be price comparable to conventional meat, whether price parity is sufficient, where he sees white spaces, and more.  So enjoy this wide-ranging conversation with a truly interesting person who’s given a lot of thought to just how he can use his role as an investor to solve some of the most pressing problems we face. Discussed in this episode Our past episodes with philosopher Peter Singer, BlueNalu’s Lou Cooperhouse, and Shiok Meat’s Sandhya Sriram. The Good Food Institute Startup Manual. More about Jim Mellon Jim Mellon’s investment philosophy is underpinned by his ability to recognize emerging trends that give rise to new industries or major shifts in markets. This includes the global financial crisis of 2008-2009, as foreseen in the first book Jim co-authored entitled Wake Up!, and subsequently in the new science and technologies detailed in Cracking the Code and Fast Forward.  More recently Jim has established himself as a thought leader in the nascent field of aging research and longevity as well as a key investor in alternative proteins, through his company Agronomics. He is interested in keeping the world healthy and properly and ethically fed and forecasts great investment opportunities in both these areas.  Jim Mellon also runs Master Investor to provide tips and forecasting insights to the investor community. His wealth of knowledge and vast experience allows him to capitalize on sound investments upon which he has built a worldwide business empire. Jim is serially amongst the top 10% in the Sunday Times Rich List and holds a master’s degree in Politics, Philosophy and Economics from the University of Oxford.

From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune.

Welcome to the Investing for Beginners podcast. In today’s show we discuss Moo’s Law with Jim Mellon: The coming disruption in the food industry from cell ag, or creation of meat products in a lab Impact on the dairy, meat, and seafood industry, plus how this all impacts the environment, the results might surprise you. […] The post The Future of the Food Industry with Jim Mellon appeared first on Investing for Beginners 101.

The agriculture industry's economic landscape is changing—and fast. Jim Mellon's new book, Moo's Law, helps readers understand the quickly evolving investment landscape in cultivated and plant-based proteins. Recently, he sat down with Sentient Media Founder Mikko Jarvenpaa to unpack the alternative protein market, what investors should be doing, what they shouldn't be doing, and what they have to look forward to.“When consumers are confronted with the choice of meat or seafood that has no hormones, no antibiotics, no toxins, nothing that's bad for you and possibly stuff that's good for you,” says Mellon, “and a very positive environmental and animal impact, why wouldn't they do it, especially if it's cheaper than the conventional stuff?”Mellon is betting that cultivated meat and seafood won't just be popular. He thinks they'll change the industry entirely. “I was skeptical when I first started writing the book that was going to happen,” says Mellon. “But I'm convinced it's going to happen now. I think [the agriculture industry] is going to be an industry that is taken over much faster than any other industry in recent history.”About Sentient MediaAll proceeds from this event go directly into funding Sentient Media.Sentient Media is a nonprofit media organization that produces independent reporting on farmed animal lives and our broken food system.Our mission is to increase public awareness of key issues that matter to all of us: the treatment and well-being of all sentient beings and the health of our planet.We believe exposure is the first step toward behavioral change. That's why we bring together journalists, digital marketing, and tech expertise to reach a diverse audience.In 2020, our animal-related content reached over 1 million readers, with over 25 million first page impressions on Google, 250 articles published on Sentient Media and 72 articles placed in outside media including The Guardian, USA Today, WIRED, NY Daily News, Citizen Truth, The Times, and more.Newsletter: https://sentientmedia.org/newsletter​ Facebook: https://facebook.com/sentientmediaorg​ Twitter: https://twitter.com/sentient_media​ Instagram: https://instagram.com/sentient_media​ LinkedIn: https://www.linkedin.com/company/sent...​

In today’s episode, Trey sits down with billionaire, Jim Mellon. They discuss Jim's new book, “Moo’s Law". The book is about the future of food and how we, as investors, can profit.CNBC has referred to Jim as “Britain’s answer to Warren Buffett” and he brings a wealth of knowledge to this very wide-ranging discussion.IN THIS EPISODE, YOU'LL LEARN:Jim Mellon’s framework for the current market conditionsThe future of foodHuman longevityThe revolution occurring in sustainable energyBOOKS AND RESOURCESMosa Meat: WebsiteBiotech anti-aging company: Juvenescence Cell-cultured sea food company: BlueNalu Jim’s new book, Moo’s Law Jim’s other booksPreston, Trey & Stig’s tool for picking stock winners and managing our portfolios: TIP Finance ToolGet a FREE book on how to systematically identify and follow market trends with Top Traders UnpluggedAutomate your money with M1 Finance. Get $30 when you sign up for free todayPush your team to do their best work with Monday.com Work OS. Start your free two-week trial todayTake your business to the next level by hiring the right people with ZipRecruiterjoin OurCrowd’s Investment in Shield—an AI-powered platform that helps global financial enterprises meet increasingly complex communications compliance rules Open your account todayInvest in high-yield, professionally managed real estate, starting with as little as $10K with EquityMultipleFind opportunities to help diversify your portfolio with investments in alternative asset classes with minimums starting at $1,000 with YieldstreetFollow other investors, discover companies to believe in, invest with any amount of money with Public.com. You’ll even get a free slice of stock when you joinSupport our free podcast by supporting our sponsors

In this episode, we bring you the unedited interview Will and Dan did with billionaire investor Jim Mellon. Because it's uncut, raw footage, you might be subject to a few 'effs and 'jeffs, so it's one for the late-night audience. The original (edited down) episode can be found HERE. If you're enjoying our podcast, please leave a review and a rating wherever you listen.

Jim Mellon is a billionaire investor who became a prominent Brexiteer around the 2016 EU referendum. Today, Jim – who built his fortune in fund management – is very much focused on business. Jim speaks to hosts Will and Dan about his interests in anti-ageing company Juvenescence and lab-grown meat investor Agronomics (he recently wrote a book called Moo's Law: An Investor's Guide to the New Agrarian Revolution). If you enjoy this episode, please consider leaving us a review on Apple Podcasts or, even better, share the podcast or this post with a friend. Previous interviewees include Gina Miller, Peter Hargreaves, Martha Lane-Fox, Spencer Matthews, Vince Cable, Charlie Mullins and Jayne-Anne Gadhia.

Jim Mellon's new book, Moo's Law, looks at the future food industry through the lens of a long-time investor. Mellon is an investor and entrepreneur who also has written numerous books on industries such as biotech and investing. For his latest book, he interviewed the who's who of the future food industry and we discuss his findings on the podcast. via Knit

Jim Mellon is an investor, entrepreneur, and author. His most recent company, Agronomics, is invested in over a dozen of the most exciting startups in the cultivated meat and plant-based meat industry. In this far-ranging interview, we dive into the investment opportunity that he's articulated in his newest book "Moo's Law: An Investor's Guide to the New Agrarian Revolution." Jim believes food technology will be one of the major investment themes of the next 50 years.This interview was recorded for Protein Report - you can check out the original video interview here.Also, check out my analysis of Blue Nalu, part of the Agronomics portfolio, "Reading the Tea Leaves for the First Cultivated Meat IPO" also on Protein Report.

Today Rob is joined by the international investor, author, and billionaire Jim Mellon. Jim is an expert in fund management, investment, and biotechnology. Together Rob and Jim discuss the impact COVID will have on business, how cycles of disruption are becoming faster and how to use your money for the greater good.   KEY TAKEAWAYS The internet has allowed the flow of information to be so much faster. The effect of that on entrepreneurship is that companies can rise and fall much faster because it is so much easier to start-up companies and therefore allows for greater competition. The internet has also allowed for collaborations en masse.   Covid is likely to be the development of novel technologies, drugs, and therapies to protect older cohorts. This is because COVID is a gerolavic disease as it mainly affects elderly people. The reason why many elderly are dying from COVID is that their immune system is compromised, the process of building up their immunity has been accelerated because we cannot afford to go through another pandemic.   There are three things everyone has got to remember. The first is ‘curiosity' if you're going to be successful you have to look at everything and see the opportunity. Secondly ‘application' is important, apply yourself daily to reach good results. Finally, focus on getting the right business model in the first place, do not try to do too much at once.   Most people who go to university at 18, really don't know what they want to do with their lives. Generally speaking, University is a good thing, you don't just learn something which may or may not be relevant to your future endeavors but you also create a large network of people.   There is nothing wrong with accumulating more money as long as you have got good intentions with it and you are not just going to sit on it and do nothing with it or abuse it. It doesn't matter how much money you have, don't waste it.   if we are going to get richer, happier, and have more time for leisure and knowledge, then you need to start thinking about what are the great upcoming trends that will eclipse everything we have seen in the past century. Those disruptive factors will have an impact on absolutely everyone, if you think you are in a safe job, you're not as everything is subject to much faster cycles of disruption than it was in the past.       BEST MOMENTS “Information can never be unlearnt.” “You make your luck” “If you want to be successful you have got to work” “If you go to bed early you will be healthy, wealthy, and wise.” “For some people that is daunting. For others, it is an opportunity.”   ABOUT THE GUEST Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics, and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific. Also, Mr. Mellon is the Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of several public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biopharma Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining, and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Jim lives in the Isle of Man, Brussels, and Ibiza and is an honorary fellow of Oriel College, Oxford. VALUABLE RESOURCES https://www.progressiveproperty.co.uk/  ABOUT THE HOST Rob Moore is an author of 9 business books, 5 UK bestsellers, holds 3 world records for public speaking, entrepreneur, property investor, and property educator. Author of the global bestseller "Life Leverage" Host of UK's No.1 business podcast "The Disruptive Entrepreneur." "If you don't risk anything, you risk everything." CONTACT METHOD Rob's official website: https://robmoore.com/ Facebook: https://www.facebook.com/robmooreprogressive/?ref=br_rs LinkedIn: https://uk.linkedin.com/in/robmoore1979   See omnystudio.com/listener for privacy information.

"There are three key things that a person needs to be successful; be curious and adaptable, read a lot, and apply yourself" - Jim Mellon Robert Emery talks to Jim Mellon, a billionaire entrepreneur-investor-philanthropist. Often in the top 10% of the Sunday Times Rich List, Jim is a visionary entrepreneur with a flair for identifying emerging global trends. Jim talks about his route to becoming one of the world's wealthiest individuals, why he believes he will live to over 100, and how humanity will shortly be feeding itself from lab-grown meat. He of course also answers a quick-fire round of questions culminating in the big question; "what is the most outrageous thing you've ever purchased?" Jim has done that rare feat of being wealthy enough to buy anything he wants in the world, but also seems like he'd be happy to have a pint with you in the local pub. He is a totally fascinating character and one we could all learn something from. With quotes like: "my talent is competent plagiarism and reducing things to simple propositions" "the people that are going to live to 110 or 120 are here - they're already alive" To see the original web page for this episode, click here: https://rdce.news/ep15

Sara and Ashley are back for the third series of Vegan Curious, the podcast for anyone interested in becoming vegan and finding more out about vegan culture. In episode 2 they speak to Stu Forsyth, CEO and Founder of the Minor Figures oat milk/coffee brand. Also in this episode * The Veganuary backlash - the meat and dairy industry strike back * Everything you need to know about cultured or lab-processed meat as featured in the new book by Jim Mellon, Moo's Law * Oatly's controversial ad campaign * The vegan restaurant with a Michelin star - does it matter? * Vegan Magnums, Higgedy vegan quiches, Huel's new savoury products, Roar ice cream and more

Jim Mellon has written Moo’s Law to provide the reader with the first-ever review of the entire alternative protein category, and the associated supply chain of meat, poultry, seafood and allied industries, and also goes a step further with his investment assessment of every leading company in this space. He is joined on this webinar with two of the leading authorities in the industry, Mark Post (Chief Scientific Officer, Mosa Meat) and Lou Cooperhouse (President & CEO of BlueNalu) for what promises to be an enlightening hour for both those familiar with the cellular agriculture sector and those who are new to the New Agrarian Revolution.

The entrepreneur Jim Mellon has a track record in investing in some of the technologies and innovations that shape our future. The one that is preoccupying him at the moment is the cultured meat market, sometimes called "cell meat". He has also written an investor's guide to the new agrarian revolution entitled Moo's Law. In this podcast The Critic's political editor, Graham Stewart, talks to Jim about the development of cultured meat and when we can expect to see it on our supermarket shelves. __ Don't forget to subscribe to the podcast on Spotify and iTunes to ensure you never you never miss an episode. Right now we're offering 3 months for just £5. Go to thecritic.imbmsubscriptions.com/ for details. __ Music: “Modern Jazz Samba” Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 4.0 License creativecommons.org/licenses/by/4.0/

The entrepreneur Jim Mellon has a track record in investing in some of the technologies and innovations that shape our future. The one that is preoccupying him at the moment is the cultured meat market, sometimes called "cell meat". He has also written an investor's guide to the new agrarian revolution entitled Moo's Law. In this podcast The Critic's political editor, Graham Stewart, talks to Jim about the development of cultured meat and when we can expect to see it on our supermarket shelves. __ Don't forget to subscribe to the podcast on Spotify and iTunes to ensure you never you never miss an episode. Right now we're offering 3 months for just £5. Go to thecritic.imbmsubscriptions.com/ for details. __ Music: “Modern Jazz Samba” Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 4.0 License creativecommons.org/licenses/by/4.0/ See acast.com/privacy for privacy and opt-out information.

Learn a little more about Henry David Thoreau as Phil Hough, Justine Murray, and Jim Mellon share their love for his essay "Walking". Hear a few passages from "Walking", as read by Jim Mellon, while sauntering in the woods or just relaxing after a long day. Full Text of "Walking": https://www.gutenberg.org/files/1022/1022-h/1022-h.htm

Bruce Friedrich, Co-founder of The Good Food Institute will be interviewed by Jim Mellon, co-founder of The Longevity Forum and Michael Corcoran, Partner at Hill Dickinson on the future of clean meat in a resilient world. Clean meat is not only better for the environment, but it also decreases dependence on antibiotics and improves food security. From cat food to cellular grown fish, we are creating new, sustainable ways to cultivate meat while avoiding the negative externalities of traditional agriculture. The field of agronomics is experiencing tremendous innovation and growth.  https://thelongevityforum.com

Longevity Week 2020 is taking place virtually on 9-13 November with an array of partner events ranging from UKRI, Zinc VC to Master Investor. The three Longevity Forum founders, Jim Mellon, Andrew Scott and Dafina Grapci-Penney discuss their favourite events coming up and why discussing resilience is so crucial with the pandemic this year. https://thelongevityforum.com

James Faulkner, Jim Mellon and Phil Newman discuss some of the amazing opportunities and challenges presented by the advancement of longevity science with particular reference to how private investors can learn more and get involved.

From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune.

In this episode of Bulletproof Radio, my guest is Jim Mellon, a British entrepreneur, investor, author and global philanthropist.We talk about the financial investments that are leading to real-time breakthroughs in human longevity, as well as developments in cellular agriculture that can feed a planet—without harming any animals.Where I think Jim is pulling a bit of a Ninja move is that he sees the goal of having old people who have brains that work and have bodies that work and have a ton of energy and a ton of wisdom. And that's the world where I'd like to live in. That's how we lift our society up. That's how we stop making the same cyclical mistakes that each generation has to figure out. So, I'm excited by that vision! “We are talking about disruption,” Jim says. “We're talking about execution. We're talking about future areas of opportunity. I would say that none of us know where it's going to end up in 10 years, but we do know that it's going to be radically different. Curiosity is a major component of success. You have to keep on seeking out and not discounting things just because they seem a bit radical.”Jim’s known for his ability to recognize emerging trends that turn into new industries or major shifts in markets. This includes the global financial crisis of 2008-2009, new science and technologies, and now the field of aging research and longevity. He’s working with biotech and life sciences companies that are looking at the mechanisms of aging. Currently underway are an FDA-approved migraine solution; a ketone ester; organ regeneration; and new drug applications.There are five things that kill 70% of the 140,000 people that die every day on the planet (excluding COVID-19): stroke, cancer, Alzheimer's, obesity, and respiratory disease. “Those diseases, which are diseases of aging, are being addressed,” Jim says.The research and product and clinical trials are moving at warp speed with the help of AI. So many people still believe that it’s not possible to influence the aging process, Jim says, but there’s incredible potential in this industry.There’s also great potential in cellular agriculture to help solve how we’ll feed the billions of people on our planet. “There's a very high level of purity and all sorts of environmental positives to it,” Jim says, “but it's sort of at a very early stage.”Listen on to learn more about the developments in longevity and sustainable food solutions that are changing our world right now.Enjoy the show! And get more resources at https://blog.daveasprey.com/category/podcasts/SPECIAL EVENT! Join the Virtual Biohacking Conference Oct. 10, 2020. You'll get "Expert Biohacking Tips and Tools For When the Fit Hits the Shan!" This interactive one-day conference is full of keynote speaker, panels, interviews, breakout sessions, unique networking opportunities and speaker meetups, a community workshop and even prizes. Get your ticket and all the details at biohackingconference.com.

In this episode of Bulletproof Radio, my guest is Jim Mellon, a British entrepreneur, investor, author and global philanthropist.We talk about the financial investments that are leading to real-time breakthroughs in human longevity, as well as developments in cellular agriculture that can feed a planet—without harming any animals.Where I think Jim is pulling a bit of a Ninja move is that he sees the goal of having old people who have brains that work and have bodies that work and have a ton of energy and a ton of wisdom. And that's the world where I'd like to live in. That's how we lift our society up. That's how we stop making the same cyclical mistakes that each generation has to figure out. So, I'm excited by that vision! “We are talking about disruption,” Jim says. “We're talking about execution. We're talking about future areas of opportunity. I would say that none of us know where it's going to end up in 10 years, but we do know that it's going to be radically different. Curiosity is a major component of success. You have to keep on seeking out and not discounting things just because they seem a bit radical.”Jim’s known for his ability to recognize emerging trends that turn into new industries or major shifts in markets. This includes the global financial crisis of 2008-2009, new science and technologies, and now the field of aging research and longevity. He’s working with biotech and life sciences companies that are looking at the mechanisms of aging. Currently underway are an FDA-approved migraine solution; a ketone ester; organ regeneration; and new drug applications.There are five things that kill 70% of the 140,000 people that die every day on the planet (excluding COVID-19): stroke, cancer, Alzheimer's, obesity, and respiratory disease. “Those diseases, which are diseases of aging, are being addressed,” Jim says.The research and product and clinical trials are moving at warp speed with the help of AI. So many people still believe that it’s not possible to influence the aging process, Jim says, but there’s incredible potential in this industry.There’s also great potential in cellular agriculture to help solve how we’ll feed the billions of people on our planet. “There's a very high level of purity and all sorts of environmental positives to it,” Jim says, “but it's sort of at a very early stage.”Listen on to learn more about the developments in longevity and sustainable food solutions that are changing our world right now.Enjoy the show! And get more resources at https://blog.daveasprey.com/category/podcasts/SPECIAL EVENT! Join the Virtual Biohacking Conference Oct. 10, 2020. You'll get "Expert Biohacking Tips and Tools For When the Fit Hits the Shan!" This interactive one-day conference is full of keynote speakers, panels, interviews, breakout sessions, unique networking opportunities and speaker meetups, a community workshop and even prizes. Get your ticket and all the details at biohackingconference.com.

‘Ageing is nothing but Evolutionary Negligence' that can be remedied by Technology. According to Dr. Kris Verburgh, Technology will help us all to live for hundreds of years, keeping our health, cognitive functions and youthful looks. This belief drives Tech companies such as Google and Amazon, to invest hundreds of millions of USD into the science of Longevity. Amongst the main Longevity investors are Jeff Bezos, Jim Mellon, Larry Page and Sergey Brin. Together with Dr. Kris Verburgh, one of the top longevity experts, author of ‘The Longevity Code' and a Venture Partner of the 100 million USD ‘Longevity Vision Fund', we discuss how Gene Editing, 3D-Bio-Printing and Stem Cell Therapy will soon be part of eradicating the root cause of lethal diseases such as cancer. Growing human organs in the bodies of GMO Pigs, will become a normal way to keep our human bodies ‘up to speed'. As the 21st century brings about a new Biotech Revolution, we will be able to program and RE-program the Human DNA. However, Bio Hacking also brings the risk of Bio Terror, i.e. create lethal viruses. The right Diet is the ‘low tech' approach to slow down the aging process. Dr. Verburgh developed the ‘Hourglass Diet' which recommends to avoid refined sugars, dairy and animal proteins as they damage our cells. Fasting is a powerful tool to help to body in repairing the damage caused by our daily lifestyle. His Key advise for Life: ‘Knowledge is Gold and Power, so read a lot. If you read only 3 books about a subject, you'll know more about it than 99% of the entire population. Be critical and check out the information you receive, especially by the media. Be kind and generous because it feels good and remember: what goes around comes around?!' More about Mentorit.TV: http://youtube.com/mentorittv More about Dr. Kris Verburgh LinkedIn: https://www.linkedin.com/in/krisverburgh/ TED-Talk: https://www.youtube.com/watch?v=C6t0iMVeXb4 Facebook: https://www.facebook.com/Kris-Verburgh-127782543902024/?ref=page_internal - - Road Trip by Joakim Karud https://soundcloud.com/joakimkarud Music promoted by Audio Library https://youtu.be/vpssnpH_H4c

Dr. Gregory Bailey is the CEO of Juvenescence, one of the biggest players in the Longevity industry. Dr. Bailey has a medical degree from the University of Western Ontario and practiced emergency medicine for more than 10 years before entering the world of finance. We talked about all the different things that Juvenescence is working on, as well as some great tips for investing in the capital starved longevity industry. If you want some advice from one of the top investors in the industry, make sure to give this a listen.Juvenescence has their hands in a lot of different pies... from participating in strategic investments where they know they can add significant value as a company, to launching products like Metabolic Switch, which can instantly turn you into ketosis, due to premier this year.The longevity industry is starved for cash, but it can be extremely daunting for someone with no formal medical training to make an intelligent investment. Dr. Bailey gives some great advice for getting around this hurdle.It was an absolute honor to speak with Dr. Gregory Bailey, and the conversation got me more excited than ever to play whatever small part I can in the industry. As his partner Jim Mellon says, this is the greatest investment opportunity in all of human history. Don't sleep on it.-James Ruhle, SimpleBioTechPodcast.comStay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTechIf you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

The Master Investor himself Jim Mellon talks to James Faulkner about his latest investing activities and thoughts on the markets. Topics covered include: Has the stock market rally gone too far too fast? Are gold and precious metals stocks a buy on the dip? Other commodity stocks of interest in an inflationary environment Clean meat and 'Moo's Law' The US election and Brexit

It is looking increasingly likely that Coronavirus will continue to affect us all for the short and, potentially, medium term. If that proves to be the case, investors should be prepared for a period of increased market uncertainty and volatility. Join master investor Jim Mellon and Netwealth's CEO Charlotte Ransom as they discuss: How investing during bear markets can be highly rewarding over the long run Strategies to deploy capital during volatile markets Cyclicals vs defensives Mental discipline and investor psychology Charlotte Ransom Charlotte is CEO of Netwealth, a challenger wealth manager. Having started her career at JP Morgan, she spent 20 years at Goldman Sachs, serving as partner for 10 years. Charlotte holds the CISI Private Client Investment Advice and Management qualification, and is one of PAM's 50 Most Influential 2019 and 2020. Jim Mellon Jim is an entrepreneur with flair for identifying emerging global trends, building a worldwide business empire. He is among the top 10% in the “Sunday Times Rich List” and often described as the British Warren Buffett. He predicted the Credit Crunch of 2007-08 in a book entitled “Wake Up! Survive and Prosper in the Coming Economic Turmoil”. Jim followed this with many other best sellers, most recently, “Juvenescence” (2017). His monthly “Mellon on the Markets” column in Master Investor Magazine has gained him cult status among investors. He holds a master’s degree in Politics, Philosophy and Economics from Oxford University James Faulkner James drew on his love of investing to pursue a career in financial media at t1ps.com, then part of the Rivington Street Holdings group of companies. James quickly progressed to become Editor-in-Chief of Master Investor and is responsible for all Master Investor content.

In this live webinar recording, James Faulkner hosts a lineup of some of the most insightful investment experts on the planet: Jim Mellon, James Ferguson and Victor Hill. The discussion delves into the coronavirus crisis and its implications for markets.

Jim Mellon, Kent Smith and myself are the Oversight Team for the LK10 Community. We have been meeting for years on a Zoom call every Thursday morning to share our lives and listen to Jesus about our Community. This week, Jim shared an amazing story about how his house church is meeting on a Zoom call on Sundays. People are flocking to be a part. People from Killeen, TX, Detroit, Seattle and Afghanistan. It's great church where everyone "get to play" just like Paul described in 1 Cor. 14:26. As Jim was sharing, I spontaneously felt led to record his story and share it as one of the episodes in Stories from the Revolution. Very grateful for my "revolutionary" friends Jim and Kent! To learn the simple "rhythms of attention" that Jim is using with his church, go to our website (LK10.com) and sign up for Church 101. Also, send this episode on to your friends who might be interested in this story about "great church in the day of social distancing".

Dafina Grapci-Penney, Jim Mellon and Andrew Scott highlight the collaborative effort of The Longevity Forum and the key takeaways from the day. The social and science narrative on longevity are changing which is very exciting for the future.  

Entrepreneur and investor Jim Mellon outlines the two themes that he thinks could be among the biggest investment stories of the 2020s, taken from his presentation at the 2019 MoneyWeek Wealth Summit in November.

The longevity industry aims to let everyone enjoy a healthy, active life well past the age of 100. But the question everyone will be asking is... will it happen in my lifetime? Manuela Saragosa reports from the Longevity Forum conference in London, where hundreds of researchers, investors, entrepreneurs and policymakers have gathered to try and answer this question. Among them, she speaks to billionaire investor Jim Mellon; London Business School economist Andrew Scott; the youthful venture capitalist Laura Deming; Columbia University geriatrician Linda Fried; and cryonics fan Anders Sandberg of the Future of Humanity Institute. Producer: Laurence Knight (Picture: Retired couple larking about on a moped; Credit: stevecoleimages/Getty Images)

In the second podcast from her sell out Edinburgh show, Merryn talks to investor and guru Jim Mellon; author, comedian and statistician Timandra Harkness, and author, comedian and presenter Simon Evans. Topics include: can you live to 150? Should you nick pills from your diabetic friends? Are monopsonies more dangerous than monopolies? Is social media the best forum for public debate ever? And, if economics is a social science, is it really a science at all?

Hi everyone and welcome to the Master Investors podcast. We’ve got a very special guest for you today. Jim Mellon is one of the most successful private investors in the UK and he’s developed a reputation for calling really big trends that have the potential to make investors a lot of money. Most recently he’s done this with biotech, which has had a phenomenal run over the past few years. But today we’re going to find out about where Jim is looking for his next money fountain, as he likes to call them. Here’s the interview and I hope you enjoy listening. Disclaimer: The value of investments can go down as well as up, so you may get back less than you invest. The information in this podcast is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. Past performance is not a reliable indicator of future returns.

This week's guest is Jim Mellon, billionaire investor, speaker, and co-author of Juvenescence: Investing in the Age of Longevity. We discuss: * His 2005 book that predicted the oncoming storm of the GFC * The coming bear market in tech stocks and why he's short Facebook * The new developments in the treatment of cancer, heart disease, lung disease, and diabetes that could significantly improve survivability * The changes in lifestyle that are already extending our lifespans Medications that could dramatically extend lifespans and healthspans * The winners, losers, and economic effects of longer lives

Facebook is "a trivial use of modern technology and one that's rather sinister," says Jim Mellon of the Burnbrae Group.

In today's show, I'll dive into the third part of a series on investing with paid research, using a book called Juvenescence by Al Chalabi and Jim Mellon. These guys have their own investment company, do all the research, and we get to benefit. They don't make lots of money on the books, it's literally the research. The book is all about researching ways of living forever, or extending the human life. In today's show, I'll talk about four companies in the space that specialize in Gene Editing technology, mentioned in the book to provide an idea of the research. SGMO, EDIT, CRSP, BLUE If you have any feedback, please send an email to alex.richwagen@gmail.com Thanks! Alex Link to book -https://www.amazon.com/Juvenescence-Investing-longevity-Mellon-Jim/dp/0993047815/ref=sr_1_1?ie=UTF8&qid=1521077298&sr=8-1&keywords=juvenescence+investing+in+the+age+of+longevity

My guest on the show today is Jim Mellon, co-author of a new book called Juvenescence. Jim is a visionary entrepreneur with a flair for identifying emerging global trends. Most notably and very publicly, he predicted the credit crunch of 2007-08 in a book entitled “Wake Up! Survive and Prosper in the Coming Economic Turmoil”. The book cited catalysts for the impending crisis including unsustainable levels of consumer debt in the western world, a U.S. housing crash, derivative financial instruments and governmental fiscal mismanagement – the rest is history! As an investor, Jim has built a worldwide business empire. He’s serially amongst the top 10% in the Sunday Times Rich List and holds a master’s degree in Politics, Philosophy and Economics from Oxford University. In his new book Juvenescence, co-authored with Al Chalabi, Jim provides a layman’s guide to longevity. It investigates the new technologies and explains how to benefit from the life extending technologies both personally and professionally. The book helps readers unravel the science, offers ideas on potential investment and reveals the views of the key opinion leaders. Here’s my conversation with billionaire investor Jim Mellon, in episode 310 of Informed Choice Radio.

In today's podcast, Alex continues his review on how to find investments by taking a paid research approach. Alex will go over another reasearch book called, Fast Forward, by Jim Mellon & Al Chalabi that you can use just like him. The paid research helps identify investments for your portfolio. This is the second in a three part series on book research. If you have questions or comments, please send an email into alex.richwagen@gmail.com, or visit the website alexrichwagen.com Stocks discussed today SGMO - CRISPR - Gene editing technology ROBO - Robotics ETF IRBT - Robotics leader - IRobot KITE - Car-T immunotherapy TON - Triton Materials - Lithium batteries IKA - Ilika - Battery charging Thanks! Alex

In today's podcast, Alex continues to answer a few emails on how to find investments by taking a paid research approach. Alex will go over a reasearch book he read called, Cracking the Code, by Jim Mellon that you can use just like him. The paid research helps identify investments for your portfolio. This is the first in a three part series on book research. If you have questions or comments, please send an email into alex.richwagen@gmail.com, or visit the website alexrichwagen.com Thanks! Alex

Welcome to the 35th CONKERS’ CORNER recorded on 21st November 2016. In this interview I have the pleasure of speaking with @timfprice Tim Price the awarding winning Fund Manager, Author and co-founder/Director of PFP Wealth Management. This business is a UK-based investment and financial advisory practice which advises on and manages £1.5 billion in client assets and is designed to provide investors with global exposure to managers pursuing value investment strategies. Tim is also a columnist for MoneyWeek magazine where he runs an investment advisory service, The Price Report gives individual investors the chance to hear the very latest views, insights and specific tips from top-level City investors and professional managers. Tim graduated with a BA in English language and literature from Christ Church, Oxford University in 1991. He “fully intended to pursue a job in Media” but sadly found that there were not that many jobs suitable for him. The first job that he could find was that of a Fixed Income Salesman in the Bond Markets in what was then a Japanese Bank. It later became Paribas Capital Markets and later Merrill Lynch. Tim helped to set up an award-winning investment management department at Ansbacher & Co. in 2001. He then moved to Union Bancaire Privée (UBP) in London where he was the Chief Investment Officer, global strategies, helping to manage over $1 billion in an absolute return programme for institutional clients. Tim Price has now worked in the capital markets for more than 25 years, his accumulated knowledge, insights and experience led to him being approached by Harriman House to write a book. The result is his first book: “Investing Through The Looking Glass: A Rational Guide to Irrational Financial Markets” for Harriman House https://harriman-house.com/search/results?res=tim+price&x=0&y=0 In his book Tim identifies and questions several investment myths and misconceptions. He questions whether stock markets inevitably rise over the longer term, whether bonds continue to be relevant as a fail safe low-risk asset and whether professional fund managers represent “smart money”. Having identified the problems besetting today’s investor, the focus then moves on to practical guidance to help investors preserve and grow their capital in this age of inflationary and deflationary uncertainty. Jim Mellon, Investor and Chairman, Burnbrae Ltd emphatically states: “Tim Price is one of the most cogent commentators on markets; this book contains wisdom and ideas that every investor should take note of. Tim has summarised the follies of Central Bankers, the avarice and general uselessness of financial advisers, and the bubble in asset prices that currently prevails. He comes up with a Manifesto which is designed to save us from the disastrous policies of the past two decades and to preserve and enhance capital. I thoroughly recommend Through the Looking Glass.” Listen now to gain insights into how Tim presents a route map for navigating one of the most challenging financial environments that anyone has ever seen. Learn from the lessons in his successful, insightful investing journey.

Welcome to the 43rd CONKERS’ CORNER recorded on 25th March 2017 at the Master Investor Show in Islington. In this interview I have the pleasure of speaking to Jim Mellon @jimmhk the renowned serial entrepreneur, self-made multi-millionaire investor, best selling author and the owner of the Master Investor Show. As one of Britain’s richest individuals with his wealth estimated to be exceeding £900 million, Jim has been described as our very own Warren Buffett. The son of a diplomat, he read Philosophy, Politics and Economics (PPE) at Oxford University, where he attained his Master’s Degree. However unlike many of his peers, he chose not go into the world of politics as he had travelled widely whilst he was young and had always intended to travel as soon he finished his studies. He was offered six jobs and chose to begin his career as a trainee Fund Manager with GT Management (now owned by Invesco) in Hong Kong. He has readily admitted that at the time, “I only had a vague idea of the workings of shares and bonds”. Jim made a great success of his time with GT Management, however when he was around 24 years of age his first boss and mentor at GT, Richard Thornton left the business. They sent about setting up their own Fund Management business and co-founded Thornton Management. By the time Jim was 28 years of age he was millionaire. After more than six years with Thornton, Jim set up his own business in 1991, now known as Charlemagne Capital and Regent Pacific. Alongside these businesses, he also has a private investment company, the Burnbrae Group, which makes up most of his vast investment endeavours, all of which have made him a potential future self made investor billionaire. Jim has also co-written several best selling books with Al Chalabi which you can find here http://www.burnbrae.com/books . Their new book “Juvenescence: Investing in the Age of longevity” will be released next month, and you can pre-order a copy now at https://www.juvenescence-book.com/ . For those that are intrigued by the title of the book, Juvenescence means “the state or period of being young”. The book discusses the benefits of a healthy life; what is good and detrimental for us and the breakthrough technologies that will enable all of us to live longer, as well as potentially invest in. In the discussion and video with Jim, he provides an insight into the journey that he has taken, which so far has encompassed Fund Management, Investing, Emerging Markets, Asia, Russia, America, Technology, Healthcare, being an Author, Private Investor and much much more. The topics we discussed include: Making informed decisions; Educational philanthropy; Pensions; Financial risks; Investing Strategy; Investment lessons learned; Russian Mafia; His life at risk; Master Investor Show; “Curiosity, Adaptability & Application”; No easy route to riches; Investing; Collaboration of information; Sharing of information; His new book : ‘Juvenescence’; Risks; Longevity. He has experienced several financial crashes and also turned around Regent Pacific from the brink of collapse after the Russian financial crisis. Jim stresses, “Like everyone, I have made a tremendous amount of mistakes”. Listen now to gain insights into how Jim Mellon selects, researches and filters his investments in order to find the best cutting edge long-term potential opportunities for his investing empire. Learn from the lessons in his successful, insightful investing journey and the thought provoking knowledge from his many investing books.

"You're going to live till you're 120 years old". That's what my guest today on Stuff That Interests Me thinks, one of Britain's most successful investors, Jim Mellon.Jim explains why - a combination of new drugs, technologies and lifestyles. What are you going to do with all your time?The next great investment trend will be around the fact that we are all going to love a lot longer. Find out more in the this fascinating interview.Juvenescence - Investing in the Age of Longevity is available from all good bookstores and at https://www.juvenescence-book.com/ See acast.com/privacy for privacy and opt-out information. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit frisby.substack.com/subscribe

"You're going to live till you're 120 years old". That's what my guest today on Stuff That Interests Me thinks, one of Britain's most successful investors, Jim Mellon. Jim explains why - a combination of new drugs, technologies and lifestyles. What are you going to do with all your time? The next great investment trend will be around the fact that we are all going to love a lot longer. Find out more in the this fascinating interview. Juvenescence - Investing in the Age of Longevity is available from all good bookstores and at https://www.juvenescence-book.com/ See acast.com/privacy for privacy and opt-out information.

James Faulkner, Editorial Director at Master Investor informs Tip TV CEO Nick Batsford about Jim Mellon’s bearish view on the UK housing market. Jim Mellon, arguably the UK's most successful private investor, is an author at Master Investor and sees a 20% fall in the housing values - pretty much across the board but more so in London. Faulkner also talks about the featured article of the month, which is centered on a company called Syndicate Room. Listen to the full show to know what’s in the offing in the latest issue of Master Investor. #MasterInvestor, #JimMellon, #trading, #investing, #UK, #housingmarket, #London, #SyndicateRoom

On this week's City A.M. Unregulated Entrepreneur Jim Mellon joins Emma Haslett and Zak Mir to discuss just how the millionaire made his wealth, how he is cashing in on an ageing population and why he thinks the Eurozone is going to be forced to disband.

Listen to the full interview with Jim Mellon on City A.M. Unregulated podcast: https://audioboom.com/channel/cityam_unregulated